Physician profile
Katherine Lichtsinn
NPI 1013918341
$1,002.52
in general payments reported to CMS, 2019-2025
12 companies · $24.09 in 2025
The $24.09 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $190 · 2020: $234 · 2021: $222 · 2022: $201 · 2023: $90.37 · 2024: $39.80 · 2025: $24.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $154.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $154.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $168.70 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $159.04 | 2019-2024 | Gardasil 9, Vaxelis, Vaxneuvance |
| Ironshore Pharmaceuticals INC. | $154.35 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $123.89 | 2019-2022 | |
| Glaxosmithkline, LLC. | $116.96 | 2019-2023 | Bexsero |
| Cranial Technologies, INC | $114.36 | 2019-2023 | Doc Band |
| Sanofi Pasteur INC. | $50.25 | 2021-2023 | |
| Sobi, INC | $30.82 | 2019-2022 | |
| Mirum Pharmaceuticals, INC. | $24.09 | 2025 | Cholbam |
| Pfizer INC. | $22.47 | 2024 | |
| Corium, LLC | $20.34 | 2022 | |
| Seqirus USA INC | $17.25 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Lichtsinn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.